Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Nausea × Thalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 39 Neoplasms, Plasma Cell 9 Vomiting 2 Recurrence 2 Neoplasms 2 Lung Neoplasms 2 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Nausea 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Kidney Neoplasms 1 Hematologic Neoplasms 1 Fallopian Tube Neoplasms 1 Disease 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

Dexamethasone 12 Ondansetron 9 Granisetron 7 Palonosetron 5 Olanzapine 5 Aprepitant 5 casopitant 3 Radiotherapy 3 Prochlorperazine 2 Electroacupuncture 2 Analgesia 2 Acupressure 2 sinomenine 1 netupitant, palosentron drug combination 1 netupitant 1 lerisetron 1 fosaprepitant 1 dolasetron 1 dexamethasone acetate 1 Therapeutics 1 Thalidomide 1 Taxes 1 Surveys and Questionnaires 1 Sugars 1 Metoclopramide 1 Hygiene 1 Haloperidol 1 Gemcitabine 1 Exercise 1 Esomeprazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06017284 2023-11-24

PTCA199-5

Fudan University

Phase 3 Recruiting

Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡